brusatol has been researched along with Colorectal Cancer in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alper, M; Ardıl, B | 1 |
| Cho, WCS; Huang, QH; Huang, Y; Lin, ZX; Xian, YF; Yang, W; Zhang, J; Zuo, Z | 1 |
| Amoreo, CA; Buglioni, S; Di Rocco, G; Di Segni, M; Mottolese, M; Soddu, S; Sperduti, I; Verdina, A | 1 |
| Kim, CW; Kim, HG; Lee, JS; Oh, ET; Park, HJ | 1 |
| Chen, HM; Chen, YL; Ip, SP; Lai, ZQ; Liao, HJ; Lin, ZX; Su, ZR; Xian, YF; Xie, JH | 1 |
5 other study(ies) available for brusatol and Colorectal Cancer
| Article | Year |
|---|---|
Potential cancer treatment effects of brusatol or eriodictyol combined with 5-fluorouracil (5-FU) in colorectal cancer cell.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Drug Synergism; Flavanones; Fluorouracil; Humans; Quassins | 2022 |
Brusatol suppresses the tumor growth and metastasis of colorectal cancer via upregulating ARRDC4 expression through modulating PI3K/YAP1/TAZ Pathway.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasm Metastasis; Phosphatidylinositol 3-Kinases; Signal Transduction | 2023 |
HIPK2 is a potential predictive marker of a favorable response for adjuvant chemotherapy in stage II colorectal cancer.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Carrier Proteins; Cell Line, Tumor; Cell Survival; Chemotherapy, Adjuvant; Colorectal Neoplasms; Drug Resistance, Neoplasm; Fluorouracil; Humans; Neoplasm Staging; NF-E2-Related Factor 2; Oxaliplatin; Protein Serine-Threonine Kinases; Quassins; Survival Analysis; Tumor Suppressor Protein p53 | 2021 |
Brusatol-Mediated Inhibition of c-Myc Increases HIF-1α Degradation and Causes Cell Death in Colorectal Cancer under Hypoxia.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Hypoxia; Colorectal Neoplasms; HCT116 Cells; HT29 Cells; Humans; Hypoxia-Inducible Factor 1; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Prolyl Hydroxylases; Proteolysis; Proto-Oncogene Proteins c-myc; Quassins; Reactive Oxygen Species | 2017 |
Synergistic antitumor effect of brusatol combined with cisplatin on colorectal cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Caspases; Cell Line, Tumor; Cell Shape; Cisplatin; Colorectal Neoplasms; Cytochromes c; Drug Synergism; Gene Expression Regulation, Neoplastic; Inhibitory Concentration 50; Mice; Quassins | 2018 |